http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014107204-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c57f1ab8eeb456235fa24732ca373ebc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133
filingDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_600fa806fd140ceee3ca5eaa36ffab9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6d05b36733d514b468e622b8bcebc60
publicationDate 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014107204-A1
titleOfInvention Method of administering ethanolamine 9-octadecanoic acid via injection to the stomach of a human
abstract The present invention provides for a method that includes safely administering via injection ethanolamine and 9-octadecanoic acid, a pharmaceutically acceptable thereof, or a pharmaceutical formulation including the same, to the stomach of a human, e.g., to prevent weight loss reversion, to induce weight loss, and/or control weight loss.
priorityDate 2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129452470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129452469

Total number of triples: 22.